Correlation Between Upstream Bio, and Amgen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Upstream Bio, and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Upstream Bio, and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Upstream Bio, and Amgen Inc, you can compare the effects of market volatilities on Upstream Bio, and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Upstream Bio, with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Upstream Bio, and Amgen.

Diversification Opportunities for Upstream Bio, and Amgen

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Upstream and Amgen is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Upstream Bio, and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and Upstream Bio, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Upstream Bio, are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of Upstream Bio, i.e., Upstream Bio, and Amgen go up and down completely randomly.

Pair Corralation between Upstream Bio, and Amgen

Considering the 90-day investment horizon Upstream Bio, is expected to under-perform the Amgen. In addition to that, Upstream Bio, is 6.66 times more volatile than Amgen Inc. It trades about -0.14 of its total potential returns per unit of risk. Amgen Inc is currently generating about -0.31 per unit of volatility. If you would invest  27,832  in Amgen Inc on October 4, 2024 and sell it today you would lose (1,768) from holding Amgen Inc or give up 6.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Upstream Bio,  vs.  Amgen Inc

 Performance 
       Timeline  
Upstream Bio, 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Upstream Bio, are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Upstream Bio, may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Amgen Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amgen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Upstream Bio, and Amgen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Upstream Bio, and Amgen

The main advantage of trading using opposite Upstream Bio, and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Upstream Bio, position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.
The idea behind Upstream Bio, and Amgen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities